Bookrunners Leerink, RBC, co-managers Needham, Wedbush PacGrow assist
By Devika Patel
Knoxville, Tenn., Sept. 30 – Nabriva Therapeutics AG said the underwriters for its initial public offering of American Depositary Shares opted to exercise the deal’s $13.84 million greenshoe in full, lifting total proceeds of the offering to $106.09 million. The deal was announced June 18 and priced for $92.25 million with the greenshoe on Sept. 18.
The company sold 10.35 million ADS at $10.25 apiece. Each ADS represents one-tenth of a common share. Of the ADS, 1.35 million were part of the fully exercised greenshoe.
Leerink Partners and RBC Capital Markets were the bookrunners.
Proceeds will be used for clinical development, working capital and other general corporate purposes.
The biopharmaceutical company is based in Vienna, Austria. It expects the ADSs to trade on the Nasdaq under the symbol “NBRV.”
| Issuer: | Nabriva Therapeutics AG
|
| Issue: | American Depositary Shares
|
| Amount: | $106,087,500, including $13,837,500 greenshoe of 1.35 million ADS
|
| ADS: | 10.35 million
|
| Price: | $10.25
|
| Warrants: | No
|
| Bookrunners: | Leerink Partners and RBC Capital Markets
|
| Co-managers: | Needham & Co. and Wedbush PacGrow
|
| Announcement date: | June 18
|
| Pricing date: | Sept. 18
|
| Settlement date: | Sept. 30
|
| Stock exchange: | Nasdaq: NBRV
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
